the Effect of Danhong Injection on Microcirculation in the Treatment of Patients With STEMI After the PTCA Surgery.
NCT02158559 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 180
Last updated 2014-06-09
Summary
This study focused on the effect of Danhong injection on microcirculation in the treatment of patients with STEMI(ST-elevation myocardical infarction) after the PTCA surgery.
Conditions
Interventions
- DRUG
-
Danhong Injection
Danhong injection 40 ml add 250 ml of 0.9% sodium chloride solution, injection intravenous drip, 1 time a day, for 7 days;
- DRUG
-
Normal Saline
0.9% sodium chloride solution 40 ml add 250 ml of 0.9% sodium chloride solution, injection intravenous drip, 1 time a day, for 7 days;
Sponsors & Collaborators
-
Beijing Bozhiyin T&S Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-03-31
- Primary Completion
- 2015-12-31
More Related Trials
-
Randomized Evaluation of Shenfu Injection to Reduce Myocardial Injury
NCT04493840 ·Status: UNKNOWN ·Phase: PHASE4
-
ShenFu Injection for Myocardial Protection in Patients With Acute ST Segment Elevation Myocardial Infarction
NCT02709798 ·Status: COMPLETED ·Phase: PHASE4
-
Stellate Ganglion Morphine Infiltration on Myocardial Ischemia-Reperfusion Injury
NCT06947135 ·Status: RECRUITING ·Phase: NA
-
Early Thrombolysis Guided by AI-Assisted App in Patients With STEMI
NCT07160491 ·Status: RECRUITING ·Phase: NA
-
Phase II Clinical Trial to Evaluate the Benefits of Postconditioning in ST-Elevation Myocardial Infarction (STEMI)
NCT01324453 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Thrombus Aspiration in Patients With STEMI
NCT02606435 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of Soluble ST2 in Patients Receiving Primary PCI With ST-elevation Myocardial Infarction
NCT02830217 ·Status: COMPLETED
-
Clinical Efficacy and SAfety of Intravenous Infusion of Nicorandil During Primary Percutaneous Coronary Intervention
NCT04665648 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluate Early Invasive Strategy for Patients With STEMI Presenting 24-48 Hours From Symptom Onset
NCT04962178 ·Status: UNKNOWN ·Phase: NA
-
Intrathrombus Thrombolysis Versus Aspiration Thrombectomy During Primary PCI
NCT05554588 ·Status: RECRUITING ·Phase: NA
-
Effects of Salvianolate Injection on Myocardial Microcirculation in Patients With Acute STEMI After Primary PCI
NCT03045562 ·Status: UNKNOWN ·Phase: PHASE4
-
Primary Reperfusion Secondary Stenting Trial
NCT01542385 ·Status: COMPLETED ·Phase: NA
-
Phase 2 Clinical Proof-of-Concept Study of the Cardioprotective Properties of Danegaptide in ST Segment Elevation Myocardial Infarction
NCT01977755 ·Status: COMPLETED ·Phase: PHASE2
-
External Validation of Ischemia and Hemorrhage Risk Models in Patients With Coronary Heart Disease
NCT07295665 ·Status: NOT_YET_RECRUITING
-
Compare Early With Deferred Invasive Strategy for STEMI Presenting 24-48 Hours From Symptom Onset
NCT04575012 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients Undergoing Primary PCI
NCT03252665 ·Status: UNKNOWN ·Phase: PHASE4
-
Intravascular Ultrasound Versus Angiography Guided Drug-coated Balloon Treatment for STEMI Patients:a Prospective, Multicenter, Randomized Controlled Trial
NCT04475978 ·Status: UNKNOWN ·Phase: NA
-
Sodium Thiosulfate to Preserve Cardiac Function in STEMI
NCT02899364 ·Status: UNKNOWN ·Phase: PHASE2
-
Etanercept Treating Patient With Acute ST Segment Elevated Myocardial Infarction
NCT01372930 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Study of Cardiomyopeptidin on Postoperative Ischemia-reperfusion Injury in Patients With Primary PCI
NCT03958422 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Morphine on Loading-dose Ticagrelor in Patients With ST-segment Elevation Myocardial Infarction
NCT02913469 ·Status: UNKNOWN ·Phase: PHASE4
-
Anfibatide Treatment in STEMI Patients
NCT02495012 ·Status: UNKNOWN ·Phase: PHASE2
-
Stellate Ganglion Morphine Infiltration on Myocardial I/R Injury
NCT07023679 ·Status: RECRUITING ·Phase: NA
-
DLBS1033 for Acute NSTEMI Without Early Coronary Revascularization
NCT02146664 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Effect of DLBS1033 After Primary PCI in Patients With STE-ACS
NCT02976701 ·Status: TERMINATED ·Phase: PHASE2/PHASE3